Specialized Medical Company vs HCA Healthcare, Inc.
A head-to-head of Specialized Medical Company (4019) and HCA Healthcare, Inc. (HCA) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | 4019 | HCA |
|---|---|---|
| Market Cap | 4.18B SAR | $80.58B |
| P/E (TTM) | 16.08 | 12.49 |
| Forward P/E | 15.21 | 13.11 |
| P/S | 2.70 | 1.26 |
| P/B | 4.18 | -16.19 |
| EV/EBITDA | 16.36 | 9.68 |
| Dividend Yield | 1.91% | 0.84% |
| Profit Margin | 17.36% | 8.89% |
| Gross Margin | 24.89% | 41.50% |
| Operating Margin | 15.82% | 15.83% |
| Revenue Growth (YoY) | +3.19% | +4.30% |
| FCF Yield | 4.78% | 8.22% |
| Debt / Equity | 52.90 | — |
| Current Ratio | 1.10 | 0.83 |
Share:
Compare Specialized Medical Company with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.